» Authors » Arzu Sayiner

Arzu Sayiner

Explore the profile of Arzu Sayiner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 160
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Guzel I, Ozturk G, Appak O, Caglayan D, Suner A, Irmak C, et al.
BMC Infect Dis . 2025 Feb; 25(1):218. PMID: 39953414
Background: Vaccine-induced neutralizing antibodies (NAbs) are key for COVID-19 protective-immunity. As the efficacy of SARS-CoV-2 vaccines declines over time and variants of the virus continue to emerge, the need for...
2.
Sanlidag Isbilen G, Aydin Uysal A, Yigit S, Appak O, Sipahi H, Bozdayi G, et al.
Turk J Med Sci . 2024 Sep; 54(4):761-765. PMID: 39295607
Background/aim: Although seasonal human coronaviruses (HCoVs) have long been recognized as respiratory tract viruses, the newly identified SARS-CoV-2 caused a pandemic associated with severe respiratory failure. We aimed to evaluate...
3.
Suner A, Ergor G, Caglayan D, Ture N, Guzel I, Irmak C, et al.
Influenza Other Respir Viruses . 2024 Aug; 18(9):e70003. PMID: 39189319
Background: This study is aimed at providing information about the timing of booster doses and antibody kinetics in healthcare workers. Methods: This research extends a prospective cohort study conducted at...
4.
Dolu S, Bengi G, Avkan-Oguz V, Tertemiz K, Gezer N, Cavus S, et al.
Turk J Gastroenterol . 2022 Aug; 33(11):955-963. PMID: 35946895
Background: In patients with coronavirus disease 2019, the gastrointestinal symptoms have been reported increasingly in addition to the respiratory system symptoms. The studies show that the prevalence of gastrointestinal system...
5.
Sayiner A, Tasbakan M, Ergan B, Kilinc O, Sayiner A, Sertoz R, et al.
Turk Thorac J . 2022 Feb; 22(3):247-250. PMID: 35110236
Objective: To evaluate the clinical features and outcomes of patients who were admitted with a diagnosis of coronavirus disease 2019 (COVID-19) but who were not confirmed with polymerase chain reaction...
6.
Caglayan D, Suner A, Siyve N, Guzel I, Irmak C, Isik E, et al.
J Med Virol . 2022 Jan; 94(5):2212-2221. PMID: 35075655
Limited data are available on the short- to midterm levels of antibodies to the CoronaVac vaccine and quantitative change in humoral response after homologous or heterologous booster doses. In this...
7.
de Vries J, Brown J, Fischer N, Sidorov I, Morfopoulou S, Huang J, et al.
J Clin Virol . 2021 Jul; 141:104908. PMID: 34273858
Introduction: Metagenomic sequencing is increasingly being used in clinical settings for difficult to diagnose cases. The performance of viral metagenomic protocols relies to a large extent on the bioinformatic analysis....
8.
Hazir-Konya H, Avkan-Oguz V, Akpinar H, Sagol O, Sayiner A
Turk J Gastroenterol . 2021 May; 32(2):123-132. PMID: 33960935
Background: In Turkey, cytomegalovirus (CMV) seropositivity has been reported to be high, between 85 and 100%. CMV has been responsible for disease exacerbation in inflammatory bowel disease (IBD). We aimed...
9.
de Vries J, Brown J, Couto N, Beer M, Le Mercier P, Sidorov I, et al.
J Clin Virol . 2021 Apr; 138:104812. PMID: 33819811
Metagenomic next-generation sequencing (mNGS) is an untargeted technique for determination of microbial DNA/RNA sequences in a variety of sample types from patients with infectious syndromes. mNGS is still in its...
10.
Yapar N, Ucan E, Bayraktar F, Gokmen N, Sayiner A, Kuruuzum Z, et al.
Turk Thorac J . 2021 Mar; 22(1):95-98. PMID: 33646113
In December 2019, in Wuhan, China, scientists observed a sudden and sharp increase in the number of cases of pneumonia and acute respiratory distress syndrome of an unknown origin. By...